Sunteți pe pagina 1din 5

Case Report

A Large Intrauterine Vascular Lesion

Developing After the Successful Treatment of
a Cesarean Scar Pregnancy with
Methotrexate Injection

Ji Won Song, MD,1 Da Hye Ju, MD,2 Sang Wook Yi, MD ,2 Joo Hee Lee, MD,1 Woo Seok Sohn, MD,2
Sang Soo Lee, MD2

Department of Obstetrics and Gynecology, Seoul Asan Hospital, University of Ulsan College of Medicine, Seoul,
Department of Obstetrics and Gynecology, Gangneung Asan Hospital, University of Ulsan College of Medicine,
Gangneung, Korea

Received 11 January 2017; accepted 22 March 2017

ABSTRACT: A cesarean scar pregnancy is a rare type hemorrhaging, many cesarean scar pregnancies
of ectopic pregnancy. Induced abortion by local meth- have been managed with medical therapy, such
otrexate (MTX) injection is an effective management as direct injection of methotrexate (MTX) into
approach. We describe a case in which a large intra- the gestational sac (GS). Some authors have
uterine vascular lesion appeared after the
suggested that transvaginal ultrasound (TVUS)-
sonographic-guided local injection of MTX, which
successfully induced the abortion of the cesarean
guided sac aspiration and local MTX injection
scar pregnancy. Although a cesarean scar pregnancy should be considered the first-line treatment for
may be safely treated with a local MTX injection, cesarean scar pregnancies.3,4
close follow-up, including serum b-human chorionic Several cases of uterine vascular lesions associ-
gonadotropin level measurement and Doppler sonog- ated with pregnancy have been reported. Rare
raphy, is needed because an intrauterine vascular cases of increase of intrauterine vascular lesions
lesion could develop even after a successfully have been reported after a successfully induced
induced abortion. VC 2017 Wiley Periodicals, Inc. J Clin
abortion of a cesarean scar pregnancy. The patho-
Ultrasound 00:000000, 2017; Published online in genesis of uterine vascular lesions is unknown and
Wiley Online Library ( DOI: placental tissue invasion into the myometrium
and neovascular formation have been suggested.5
Keywords: cesarean scar pregnancy; obstetrics; local Because the amount of bleeding from the lesions
methotrexate injection; ultrasound; uterus may be profuse, careful diagnosis and manage-
ment of such uterine vascular lesions are required.
We recently encountered a case involving a
INTRODUCTION large intrauterine vascular lesion that devel-
oped following the local MTX injection to induce
C esarean scar pregnancy is a rare type of
ectopic pregnancy with an incidence of
1:1,8001:2,216 among all pregnancies.1,2 It can
the abortion of a cesarean scar pregnancy. In
this case, an intrauterine vascular lesion was
formed despite the successful abortion.
produce massive hemorrhage due to gestational
tissue implantation in the lower segment of the
uterus. Due to the risk of profuse
Correspondence to: S. W. Yi
A 35-year-old multiparous woman was referred
C 2017 Wiley Periodicals, Inc.
V to our hospital for suspicion of a cervical
VOL. 00, NO. 00, MONTH 2017 1

pregnancy and amenorrhea for 8 weeks. Her

history included one full-term vaginal delivery,
one cesarean section, followed by two vaginal
deliveries. TVUS examination performed with
an Accuvix A30 scanner equipped with a 49-
MHz endocavity transducer (Samsung Medison
Co. Ltd., Seoul, Korea) revealed a 3.6 3 2.1-cm
GS with a 0.95 cm crown-rump length and an
active fetal heartbeat near the cesarean scar
(Figure 1). The uterus was slightly enlarged
due to adenomyosis, and no pathologic findings
were observed in the bilateral adnexae. No oth-
er gestational tissues were observed in the
endometrial cavity or adnexa. The patients b-
human chorionic gonadotropin (b-hCG) serum
level was 17,926 mIU/ml.
After counseling regarding the risk of uterine
rupture, massive bleeding, and hysterectomy,
the patient underwent transvaginal aspiration
of the GS and an injection of MTX to preserve
her uterus. The procedure was performed under
transabdominal ultrasound (US) guidance, with
the patient in the lithotomy position, without
anesthesia. The GS was punctured and aspirat-
ed with an 18-gauge spinal needle. After aspira-
tion, 90 mg of MTX (50 mg/m2) was injected
slowly through the spinal needle. Serum b-hCG
testing was performed on days 1 and 5 and
then weekly to evaluate the success of the pro-
cedure. On the day after the procedure, the FIGURE 1. (A) Transvaginal sonogram revealed a 3.6 3 2.1-cm gesta-
patients b-hCG serum level was 16,572 mIU/ tional sac near the cesarean scar with a 0.95-cm crown-rump length.
ml, and no fetal heartbeat was detected. There- (B) Sonogram confirms an active fetal heartbeat.
fore, the patient was discharged and the need
for weekly follow-up to monitor her serum b- outpatient basis. Two weeks after the emboliza-
hCG levels was explained. tion, the patient experienced an episode of vagi-
The patients b-hCG serum levels after 5 days nal bleeding, which was treated conservatively.
and after 7 days were 20,490 mIU/ml and The serum b-hCG level normalized after 57
48,702 mIU/ml, respectively. TVUS with color days, and the patient had a regular menstrual
Doppler revealed a large vascular lesion in the period 2 months after the embolization. TVUS
uterus near the regressed GS without a fetal with color Doppler performed 124 days after the
heartbeat (Figure 2). The patient was admitted embolization showed the remnant tissue of the
to the hospital. CT angiography revealed an 8 3 cesarean scar pregnancy as a 0.9-cm avascular
4-cm vascular lesion on the right side of the echogenic mass (Figure 5). No additional inter-
uterine body with enlarged uterine arteries and vention or uterine curettage was performed.
ovarian veins (Figure 3). The vascular lesion
originated from the point where both uterine
arteries drained into the right side of the parau- DISCUSSION
terine venous plexus and gonadal vein (Figure
4). Bilateral uterine arterial embolization with Treatment modalities for cesarean scar preg-
a coil and gelfoam was performed following sys- nancy range from medical interventions to sur-
temic MTX chemotherapy. On the following day, gical procedures, uterine artery embolization,
the patients b-hCG serum level was 4,760 mIU/ chemoembolization, or a combination of them.
ml. The recovery period was uneventful. The Cok et al reported using TVUS-guided local
patient was discharged, and follow-up visits to MTX administration as the first-line treatment
monitor the serum b-hCG levels and undergo for cesarean scar pregnancy in 18 cases with
US examinations were performed on an follow-up.4 They reported that 11 of the 18

FIGURE 2. (A) Transvaginal gray-scale sonogram shows an anechoic lesion in the uterus near the regressed gestational sac (white arrow). (B) Col-
or Doppler confirms the blood flow in the vascular lesion.

FIGURE 3. CT scan shows an enhanced vascular lesion (white arrow) around the gestational sac (black arrow) in the cesarean section scar

patients (61.1%) did not require further inter- scar pregnancies, both uterine arterial emboli-
vention. Four patients (22.2%) were treated zation and MTX conservative treatment
with an additional single dose of systemic MTX, achieved the expected therapeutic effect, and
and three patients required a hysteroscopy and/ the recovery time in the dilatation and curet-
or laparotomy. Yamaguchi et al retrospectively tage subgroup was significantly shorter than in
reviewed eight cases of cesarean scar pregnancy the noncurettage group.7 Considering these
treated with a local MTX injection under TVUS reports, we treated our patient with a transva-
guidance.6 They concluded that a transvaginal ginal local MTX injection under transabdominal
MTX injection was effective and safe as the sole US guidance. After the local MTX injection, the
treatment for cesarean scar pregnancy, although fetal heartbeat ceased, and the serum -hCG
the course after treatment tended to be long. In level decreased. Generally, after a local MTX
a retrospective clinical study of 131 cesarean injection, a decline in the serum -hCG level
VOL. 00, NO. 00, MONTH 2017 3

FIGURE 4. CT angiography with reconstruction. There is an 8 3 4-cm vascular lesion in the right side of the uterine body with enlarged uterine
arteries and ovarian veins.

FIGURE 5. Transvaginal sonogram obtained 124 days after the embolization shows the 0.9-cm echogenic remnant tissue of the cesarean scar
pregnancy (arrow). Calipers showed longitudinal diameter and anterioposterior diameter of the uterus.

indicates regression of the conception tissue. In one case series, a small (<3 cm) intrauter-
However, the placental tissue can be activated ine vascular lesion was observed following a
despite the induction of an abortion. successfully induced abortion using a local MTX

injection. The pathogenesis of intrauterine vas- measurement and color Doppler US, is needed
cular lesions is unclear. Some authors have sug- because an intrauterine vascular lesion could
gested that trophoblasts such as the retained occur even after a successfully induced abortion.
placenta might play a role as a precursor of the
lesion. The placental tissue may have been
involved in vascular disruption and neovascula- REFERENCES
rization.5 One case of a cesarean scar pregnancy 1. Seow KM, Huang LW, Lin YH, et al. Cesarean scar
associated with a uterine artery pseudoaneur- pregnancy: issues in management. Ultrasound
ysm has been reported.8 This case involved a Obstet Gynecol 2004;23:247.
uterine arterial pseudoaneurysm and a cesare- 2. Jurkovic D, Hillaby K, Woelfer B, et al. First-tri-
an scar pregnancy without a fetal heartbeat. In mester diagnosis and management of pregnancies
our case, a large intrauterine vascular lesion implanted into the lower uterine segment Cesare-
was observed following a successful abortion, an section scar. Ultrasound Obstet Gynecol 2003;
producing a sudden increase in the serum - 21:220.
hCG level. Because intrauterine vascular 3. Seow KM, Wang PH, Huang LW, et al. Transvagi-
lesions greater than 3 cm in size with increas- nal sono-guided aspiration of gestational sac con-
ing serum -hCG levels tend to continue to current with a local methotrexate injection for the
increase or persist, interventional management treatment of unruptured cesarean scar pregnancy.
Arch Gynecol Obstet 2013;288:361.
is needed.5 Therefore, careful monitoring of the
4. Cok T, Kalayci H, Ozdemir H, et al. Transvaginal
serum -hCG level and Doppler sonography
ultrasound-guided local methotrexate administra-
after a local MTX injection for a cesarean scar tion as the first-line treatment for cesarean scar
pregnancy are required. pregnancy: follow-up of 18 cases. J Obstet Gynae-
The treatment options for intrauterine vascu- col Res 2015;41:803.
lar lesions include hysterectomy, uterine arteri- 5. Ju da H, Yi SW, Sohn WS, et al. Acquired uterine
al embolization, chemotherapy with MTX, and vascular abnormalities associated with persistent
conservative management.5 Due to the possibili- human chorionic gonadotropin: experience at a
ty of profuse vaginal bleeding, patients should Korean teaching hospital. Taiwan J Obstet Gyne-
be referred to a center with an interventional col 2015;54:654.
radiology unit. Curettage can cause heavy and 6. Yamaguchi M, Honda R, Uchino K, et al. Transva-
life-threatening bleeding if the diagnosis of vas- ginal methotrexate injection for the treatment of
cular abnormalities is not made prior to the cesarean scar pregnancy: efficacy and subsequent
fecundity. J Minim Invasive Gynecol 2014;21:877.
intervention. Tan et al described a case of a
7. Yang H, Li S, Ma Z, et al. Therapeutic effects of
cesarean section pregnancy associated with a
uterine artery embolisation (UAE) and methotrex-
uterine artery pseudoaneurysm.8 They per- ate (MTX) conservative therapy used in treatment
formed uterine arterial embolization followed by of cesarean scar pregnancy. Arch Gynecol Obstet
curettage under sonographic guidance 1 week 2016;293:819.
later. 8. Tan J, Xue Q, Ling J, et al. Cesarean scar pregnan-
A cesarean scar pregnancy may be safely cy associated with uterine artery pseudoaneurysm:
treated with a local MTX injection. However, a case report. Clin Exp Obstet Gynecol 2015;42:
close follow-up, including serum -hCG level 835.

VOL. 00, NO. 00, MONTH 2017 5